News

Valeant is expected to pay Spear a $12m upfront payment and the two companies will share net profits. Valeant will book sales and use its dermatology sales force

Corgenix’ new format offers high-volume testing labs the same performance as the currently available Corgenix rapid assay with improved efficiency and high-volume analysis. Automated microplate Elisa processing from

Merrion Pharma claimed that the enhancers covered by the patent have the ability to enhance oral absorption many fold compared to standard formulations. The technology can therefore be

Ospemifene is a SERM designed to mimic the positive effects of estrogen on the vaginal epithelium while avoiding estrogen stimulation of breast and other tissues. As per the

Epinex said that the granted patent (US7659107B2) is for the rapid glycated albumin test and instrument, which could redefine the way diabetes is monitored for over 250 million

The membrane based technology of the start-up company MET, which can be applied to a wide range of chemical processes, simplifies product purification and generates substantial energy cost

Earlier, in 2007, Renovo and Shire signed a licensing agreement giving Shire the rights to sell Juvista throughout the world excluding the EU which Renovo retained. Juvista is

The Belatacept Biologics license application was submitted to the FDA for an indication of prophylaxis of organ rejection and preservation of a functioning allograft in adult patients receiving

The syndicate, which also includes Green Biologics and The Centre for Process Innovation, is designing Stratophase’s SpectroSens technology. Stratophase is heading a $1.8m project aimed at catering to